IMNM vs AAPL: Which Stock is Better?
Side-by-side comparison of Immunome Inc and Apple Inc in 2026
IMNM
Immunome Inc
$22.61
AAPL
Apple Inc
$258.66
Key Metrics Comparison
| Metric | IMNM | AAPL | Winner |
|---|---|---|---|
| Market Cap | $2.45B | N/A | IMNM |
| P/E Ratio | N/A | 32.77 | AAPL |
| EPS (TTM) | $N/A | $7.91 | AAPL |
| Revenue Growth | -1.0% | 0.2% | AAPL |
| Gross Margin | -2454.2% | 47.3% | AAPL |
Analyze IMNM
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMNM or AAPL a better investment?
Comparing IMNM and AAPL: Immunome Inc has a market cap of $2.45B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMNM and AAPL?
IMNM (Immunome Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMNM or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMNM or AAPL?
AAPL has higher revenue growth at 0.2% vs -1.0% for IMNM.
Which company is more profitable: IMNM or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to -2454.2% for IMNM.
Which is the larger company: IMNM or AAPL?
Immunome Inc (IMNM) is larger with a market cap of $2.45B compared to N/A for AAPL.
Should I buy IMNM or AAPL in 2026?
Both IMNM and AAPL have investment merit. IMNM trades at $22.61 while AAPL trades at $258.66. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMNM and AAPL stock?
Key differences: Market Cap ($2.45B vs N/A), P/E Ratio (N/A vs 32.8x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (-2454.2% vs 47.3%).